{"id":1068491,"date":"2024-03-18T02:36:15","date_gmt":"2024-03-18T06:36:15","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/nurexones-strategic-update-submission-of-otcqb-listing-application-to-initiate-us-financial-presence\/"},"modified":"2024-08-18T11:47:56","modified_gmt":"2024-08-18T15:47:56","slug":"nurexones-strategic-update-submission-of-otcqb-listing-application-to-initiate-us-financial-presence","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/nurexones-strategic-update-submission-of-otcqb-listing-application-to-initiate-us-financial-presence.php","title":{"rendered":"NurExone&#8217;s Strategic Update: Submission of OTCQB Listing Application\u00a0to Initiate US financial presence"},"content":{"rendered":"<p><![CDATA[TORONTO and HAIFA, Israel, March  15, 2024  (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the \u201cCompany\u201d or \u201cNurExone\u201d), a pioneering biopharmaceutical company, developing regenerative medicine therapies, announces today its intention to broaden its market reach through a recently filed application for listing on the OTCQB\u00ae Venture Market (the \"OTCQB\") in the United States. Listing on the OTCQB is subject to approval of the OTC Markets Group.]]><\/p>\n<p>Read more from the original source:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/03\/15\/2847297\/0\/en\/NurExone-s-Strategic-Update-Submission-of-OTCQB-Listing-Application-to-Initiate-US-financial-presence.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"NurExone's Strategic Update: Submission of OTCQB Listing Application\u00a0to Initiate US financial presence\">NurExone's Strategic Update: Submission of OTCQB Listing Application\u00a0to Initiate US financial presence<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read more from the original source: NurExone's Strategic Update: Submission of OTCQB Listing Application\u00a0to Initiate US financial presence <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/nurexones-strategic-update-submission-of-otcqb-listing-application-to-initiate-us-financial-presence.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068491","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068491"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068491"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068491\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068491"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068491"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068491"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}